<DOC>
	<DOCNO>NCT01852383</DOCNO>
	<brief_summary>Dysthymic disorder ( DD ) denote chronic depression few symptom major depressive disorder ( MDD ) , affect ~ 2-4 % adult similar prevalence elderly . In elderly , dysthymic disorder ( DD ) show associated suffering disability . The difference young adult elderly DD patient indicate finding obtain young adult DD extrapolate elderly DD patient need study separately . Data epidemiologic study support view . In contrast data young adult DD patient , paucity control data treatment elderly DD patient . In center , double-masked , placebo-controlled study 91 elderly DD patient find significant superiority fluoxetine placebo response rate 27.3 % fluoxetine 19.6 % placebo intent-to-treat analysis , response rate 37.5 % fluoxetine 23.1 % placebo completer analysis . Given relative failure selective serotonin reuptake inhibitor ( SSRIs ) treat geriatric DD effectively , investigator decide evaluate dual reuptake inhibitor , venlafaxine . The investigator earlier complete investigator-initiated , open-label 12-week venlafaxine ( Effexor XR ) trial . Of 23 elderly DD patient , 18 complete trial . Fourteen ( 60.9 % ) responders intent-to-treat analysis last observation carry forward , 77.8 % responder completer analysis . Nearly half sample ( 47.8 % ) meet criteria remission . In intent-to-treat sample , increased severity depression baseline associate superior response presence cardiovascular disease associate poor response . These result venlafaxine indicate treatment study dual serotonin-norepinephrine reuptake inhibitor like duloxetine warrant elderly patient dysthymic disorder .</brief_summary>
	<brief_title>Duloxetine Treatment Elderly With Dysthymia</brief_title>
	<detailed_description>HYPOTHESES : 1 . Duloxetine reduce depressive symptomatology period 12 week elderly DD patient . 2 . Duloxetine-treated dysthymic patient significant improvement measure overall functioning . This pilot trial enrol 30 patient ≥ 60 year old dysthymic disorder . Patients recruit clinician referral radio newspaper advertisement offer free evaluation experience clinician participation clinical trial Adult Late Life Depression Clinic New York State Psychiatric Institute . After telephone screen rule exclusion enrollment clinic , psychiatrist conduct detailed evaluation complete Cumulative Illness Rating Scale ( CIRS ) -Geriatric [ CIRS-G ] . Patients provisional clinical diagnosis dysthymic disorder interview research rater ( social worker nurse ) Structured Clinical Interview Diagnostic Statistical Manual Mental Disorders , 4th edition ( DSM-IV ) Axis I disorders- Patient edition ( SCID-P ) . Based psychiatrist 's evaluation SCID-P interview , consensus DSM-IV diagnosis make staff conference .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Dysthymic Disorder</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Diagnosis dysthymic disorder ( SCID DSMIV ) Age 60 95 MiniMental State Score ≥ 24 24item Hamilton Rating Scale Depression score 1225 Willing capable give informed consent Current major depressive episode ( SCID DSMIV ) Alcohol substance dependence last year ( SCID DSMIV ) Bipolar disorder , schizophrenia psychotic disorder ( SCID DSMIV ) Clinical stroke , dementia , Huntington 's disease , epilepsy major neurological disease Acute unstable medical condition Active suicidal ideation plan Nonresponse duloxetine ( minimum 90 mg/day 6 week ) past year A positive urine drug screen substance abuse dependence Sensitivity intolerability duloxetine Use medication may interact duloxetine , include inhibitor cytochrome P450 1A2 ( CYP1A2 ) cytochrome P450 2D6 ( CYP2D6 ) , e.g. , quinolone antibiotic type 1C antiarrhythmic . Several antidepressant medication , include SSRIs , inhibitor CYP2D6 medication permit antidepressant treatment trial . Patients hypertension ( BP &gt; 140/90 mm Hg 2 consecutive measurement ) . For patient treated hypertension BP &gt; 140/90 , write approval must obtain patient 's internist allow participate study . Known liver damage disease</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Duloxetine</keyword>
	<keyword>Antidepressant</keyword>
	<keyword>Depression</keyword>
	<keyword>Dysthymic Disorder</keyword>
	<keyword>Side Effects</keyword>
	<keyword>Elderly</keyword>
</DOC>